News For Gilead Sciences


This RSS feed URL is deprecated

This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news
Google 27/05/2018 13:54:28

3 Healthcare Stocks That Are Undeniably Dirt Cheap Right Now - Motley Fool


Motley Fool

3 Healthcare Stocks That Are Undeniably Dirt Cheap Right Now
Motley Fool
And there are three healthcare stocks that are undeniably dirt cheap right now based on the metric: United Therapeutics (NASDAQ:UTHR), Gilead Sciences (NASDAQ:GILD), and Humana (NYSE:HUM). But are these cheap stocks smart picks to buy?

Google 27/05/2018 10:32:00

AIDS Healthcare Foundation, Inc. v. Gilead Sciences, Inc. (Fed. Cir. 2018) - JD Supra (press release)


JD Supra (press release)

AIDS Healthcare Foundation, Inc. v. Gilead Sciences, Inc. (Fed. Cir. 2018)
JD Supra (press release)
The case arose when AIDS Healthcare Foundation (AHF) filed suit against defendants Gilead Sciences, Inc., Japan Tobacco Inc., Johnson & Johnson, and Janssen Sciences Ireland UC over various drugs comprising the anti-HIV compound tenofovir ...

Google 25/05/2018 22:26:53

Is Gilead Sciences Inc (NASDAQ:GILD) A Smart Choice For Dividend Investors? - Simply Wall St


Is Gilead Sciences Inc (NASDAQ:GILD) A Smart Choice For Dividend Investors?
Simply Wall St
Dividends play an important role in compounding returns in the long run and end up forming a sizeable part of investment returns. In the past 3 years Gilead Sciences Inc (NASDAQ:GILD) has returned an average of 3.00% per year to investors in the form ...

Google 24/05/2018 18:56:15

Gilead: Novartis's Kymriah Is Coming To America - Seeking Alpha


Gilead: Novartis's Kymriah Is Coming To America
Seeking Alpha
The new indication puts Kymriah in direct competition with Gilead Sciences' Yescarta, which was approved by the U.S. Food and Drug Administration in October for treatment of adults with diffuse large B-cell lymphoma who have failed to respond to other ...

Google 24/05/2018 07:45:42

Gilead Sciences to Present at the Jefferies 2018 Healthcare Conference on Wednesday, June 6 - Business Wire (press release)


Business Wire (press release)

Gilead Sciences to Present at the Jefferies 2018 Healthcare Conference on Wednesday, June 6
Business Wire (press release)
FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced that John F. Milligan, PhD, Gilead's President and Chief Executive Officer; Robin L. Washington, Gilead's Executive Vice President and Chief Financial Officer; ...
The Silver Lining In Gilead Sciences, Inc. (GILD), Cinemark Holdings, Inc. (CNK)Post Analyst
How Does Gilead Sciences, Inc. (GILD) Stack Up Right Now?StockNewsJournal
A Comparison of Top Movers: Gilead Sciences, Inc. (GILD), The Western Union Company (WU)StockNewsGazette
Stock Watch -Motley Fool -Seeking Alpha -StreetInsider.com
all 210 news articles »
Google 23/05/2018 20:01:00

Former Gilead R&D chief to lead cancer drug startup in Cambridge - Boston Business Journal


Boston Business Journal

Former Gilead R&D chief to lead cancer drug startup in Cambridge
Boston Business Journal
One month after stepping down as head of research and development at Gilead Sciences, Norbert Bischofberger has taken the helm of a new cancer drug startup in Cambridge. Kronos Bio formally announced its launch on Wednesday. The company is ...
Norbert Bischofberger helped Gilead (NASDAQ: GILD) score billions ...San Francisco Business Times
Kronos Bio Appoints Dr. Norbert Bischofberger, Former Head of R&D for Gilead Sciences, as President and Chief ...Business Wire (press release)

all 4 news articles »
Google 23/05/2018 10:19:46


 1 2